Repurposing Antibody-Drug Conjugates for Theranostic Targeting of Nectin-4 and TROP2 in Bladder Cancer. Wood JL, Lum B, Ghosh S, Staudacher AH, et al. Mol Pharm 2026;23:5879-5890.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wood JL, Lum B, Ghosh S, Staudacher AH, et al. Repurposing Antibody-Drug Conjugates for Theranostic Targeting of Nectin-4 and TROP2 in Bladder Cancer. Mol Pharm 2026;23:5879-5890.
PMID: 42969724